ArticleClinical ophthalmology (Auckland, N.Z.)2026
Development and Clinical Accuracy of the New Paraxial Ray-Tracing IOL Power Formula (VRT) Based on the Thin Lens Assumption.
Article in Clinical ophthalmology (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To develop and evaluate the refractive and clinical accuracy of the novel IOL power calculation formula (VRT) in unoperated Caucasian eyes. Methods: This retrospective and single-center study included 1016 eyes of 1016 patients, all operated on by a single surgeon using PARTIAL-RoF narrow IOL (Tecnis 1 ZCB00, Johnson & Johnson Vision, Jacksonville, FL, USA). The complete data set was divided into two groups: the first was used to develop the new formula (489 eyes), and the second-the test group (527 eyes)-was used to assess its performance alongside other formulas (Barrett Universal II (BUII), Haigis, Hoffer Q, Hoffer QST, Holladay 1, Cooke K6, Kane, Norrby RT, Olsen (OLCR), Olsen (standalone), Pearl-DGS, SRK/T, VRF, and VRF CMAL). The VRT formula is based on a paraxial ray-tracing method that employs two constants and the thin-lens assumption. The ELP algorithm was adopted from the VRF formula, incorporating the Cooke-modified axial length (CMAL) correction. Subgroup analysis was also stratified by axial length as follows: short (≤22.00 mm), medium (22.01-25.99 mm), and long (≥26.00 mm). Preoperative examination was performed using the SS-OCT biometer (IOLMaster 700; Carl Zeiss Meditec AG). All descriptive statistics were analyzed using optimized lens constants. Results: The VRT formula demonstrated the highest accuracy (SD 0.358 D), outperforming all traditional formulas (Haigis, Hoffer Q, Holladay 1, SRK/T), modern thin lens formulas (VRF), and some ray-tracing methods (Norrby RT, Olsen (OLCR), Olsen (standalone); P < 0.05). Meanwhile, the new formula showed comparable accuracy with modern methods such as BUII, Hoffer QST, Cooke K6, Kane, and Pearl-DGS (P > 0.05). Conclusion: The VRT formula showed promising results, outperformed traditional formulas, and was comparable to modern IOL power calculation methods in Caucasians, using one IOL model, which can be considered a limitation of this study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.